MKI67 and metastatic neoplasm: Albeit repeating biopsy of metastatic disease to re-assess proliferative activity has been proposed in the literature, especially in the cases with rapidly progressive tumors or if imaging information is lacking [5, 6], very few studies have investigated Ki67 variability over the course of the disease in EP-NEN patients.